Several pathogenic mechanisms have been postulated, including hyperglycemia and its enzymatic glycation end products, insulin resistance, hypoglycemia, micro and macrovascular disease, inflammation, oxidative stress, in addition to alterations in the metabolism of amyloid peptides, amylin, and tau protein. The gene discussed is MAPT; the disease is Hypoglycemia.